Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05759949 |
Title | First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Relay Therapeutics, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Sarah Cannon Research Institute at Florida Cancer Specialists | Orlando | Florida | 32827 | United States | Details | |
Community Cancer Center North | Indianapolis | Indiana | 46250 | United States | Details | |
Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | United States | Details | |
Memorial Sloan Kettering Cancer Center-Main Campus | New York | New York | 10065 | United States | Details | |
Tennessee Oncology, PLLC | Nashville | Tennessee | 37203 | United States | Details | |
Huntsman Cancer Institute, University of Utah | Salt Lake City | Utah | 84112 | United States | Details |